Target-specific delivery of doxorubicin to human glioblastoma cell line via ssDNA aptamer

Targeted drug delivery approaches have been implementing significant therapeutic gain for cancer treatment since last decades. Aptamers are one of the mostly used and highly selective targeting agents for cancer cells. Herein, we address a nano-sized targeted drug delivery approach adorned with A-17...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biosciences 2018-03, Vol.43 (1), p.97-104
Main Authors: Bayrac, Abdullah Tahir, Akca, Oya Ercan, Eyidogan, Fusun Inci, Oktem, Huseyin Avni
Format: Article
Language:English
Subjects:
Aptamers
Biomedical and Life Sciences
Biomedicine
Brain cancer
Breast cancer
Cancer
Cell Biology
Cell lines
Cytometry
Cytotoxicity
Deoxyribonucleic acid
DNA
Doxorubicin
Drug delivery
Drug delivery systems
Drugs
Flow cytometry
Glioblastoma
Life Sciences
Microbiology
Plant Sciences
Toxicity
Transport
Tumor cell lines
Tumors
Zoology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c372t-b6945137a9db84a40827770742e2901e345ae8d65e67dd1bec6eaaa44c4c3fa3
cites cdi_FETCH-LOGICAL-c372t-b6945137a9db84a40827770742e2901e345ae8d65e67dd1bec6eaaa44c4c3fa3
container_end_page 104
container_issue 1
container_start_page 97
container_title Journal of biosciences
container_volume 43
creator Bayrac, Abdullah Tahir
Akca, Oya Ercan
Eyidogan, Fusun Inci
Oktem, Huseyin Avni
description Targeted drug delivery approaches have been implementing significant therapeutic gain for cancer treatment since last decades. Aptamers are one of the mostly used and highly selective targeting agents for cancer cells. Herein, we address a nano-sized targeted drug delivery approach adorned with A-172 glioblastoma cell-line-specific single stranded DNA (ssDNA) aptamer in which the chemotherapeutic agent Doxorubicin (DOX) had been conjugated. DNA aptamer, GMT-3, was previously selected for specific recognition of glioblastoma and represented many advantageous characteristics for drug targeting purposes. Flow cytometry analysis proved the binding efficiency of the specific aptamer to tumour cell lines. Cell-type-specific toxicity of GMT-3:DOX complex was showed by XTT assay and terminated cytotoxic effects were screened for both target cell and a control breast cancer cell line. The result of this contribution demonstrated the potential utility of GMT-3 aptamer-mediated therapeutic drug transportation in the treatment of gliomas specifically. It was concluded that aptamer-mediated drug delivery can be applied successfully for clinical use.
doi_str_mv 10.1007/s12038-018-9733-x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1993571498</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1993571498</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-b6945137a9db84a40827770742e2901e345ae8d65e67dd1bec6eaaa44c4c3fa3</originalsourceid><addsrcrecordid>eNp1kLtOwzAUhi0EgnJ5ABZkidlgx05tj1W5ShUsXZgsxzkpRklc7KRq356gFMTCdH7p_BfpQ-iS0RtGqbxNLKNcEcoU0ZJzsj1AEzooIhlXh4POckpyrdkJOk3pg1KmBafH6CTTQuWMqQl6W9q4go6kNThfeYdLqP0G4g6HCpdhG2JfeOdb3AX83je2xavah6K2qQuNxQ7qGte-BbzxFqd09zLDdt3ZBuI5OqpsneBif8_Q8uF-OX8ii9fH5_lsQRyXWUeKqRY549LqslDCCqoyKSWVIoNMUwZc5BZUOc1hKsuSFeCmYK0VwgnHK8vP0PVYu47hs4fUmY_Qx3ZYNExrnksmtBpcbHS5GFKKUJl19I2NO8Oo-WZpRpZmYGm-WZrtkLnaN_dFA-Vv4gfeYMhGQxpe7Qrin-l_W78AVe9_4w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1993571498</pqid></control><display><type>article</type><title>Target-specific delivery of doxorubicin to human glioblastoma cell line via ssDNA aptamer</title><source>Springer Link</source><creator>Bayrac, Abdullah Tahir ; Akca, Oya Ercan ; Eyidogan, Fusun Inci ; Oktem, Huseyin Avni</creator><creatorcontrib>Bayrac, Abdullah Tahir ; Akca, Oya Ercan ; Eyidogan, Fusun Inci ; Oktem, Huseyin Avni</creatorcontrib><description>Targeted drug delivery approaches have been implementing significant therapeutic gain for cancer treatment since last decades. Aptamers are one of the mostly used and highly selective targeting agents for cancer cells. Herein, we address a nano-sized targeted drug delivery approach adorned with A-172 glioblastoma cell-line-specific single stranded DNA (ssDNA) aptamer in which the chemotherapeutic agent Doxorubicin (DOX) had been conjugated. DNA aptamer, GMT-3, was previously selected for specific recognition of glioblastoma and represented many advantageous characteristics for drug targeting purposes. Flow cytometry analysis proved the binding efficiency of the specific aptamer to tumour cell lines. Cell-type-specific toxicity of GMT-3:DOX complex was showed by XTT assay and terminated cytotoxic effects were screened for both target cell and a control breast cancer cell line. The result of this contribution demonstrated the potential utility of GMT-3 aptamer-mediated therapeutic drug transportation in the treatment of gliomas specifically. It was concluded that aptamer-mediated drug delivery can be applied successfully for clinical use.</description><identifier>ISSN: 0250-5991</identifier><identifier>EISSN: 0973-7138</identifier><identifier>DOI: 10.1007/s12038-018-9733-x</identifier><identifier>PMID: 29485118</identifier><language>eng</language><publisher>New Delhi: Springer India</publisher><subject>Aptamers ; Biomedical and Life Sciences ; Biomedicine ; Brain cancer ; Breast cancer ; Cancer ; Cell Biology ; Cell lines ; Cytometry ; Cytotoxicity ; Deoxyribonucleic acid ; DNA ; Doxorubicin ; Drug delivery ; Drug delivery systems ; Drugs ; Flow cytometry ; Glioblastoma ; Life Sciences ; Microbiology ; Plant Sciences ; Toxicity ; Transport ; Tumor cell lines ; Tumors ; Zoology</subject><ispartof>Journal of biosciences, 2018-03, Vol.43 (1), p.97-104</ispartof><rights>Indian Academy of Sciences 2018</rights><rights>Journal of Biosciences is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-b6945137a9db84a40827770742e2901e345ae8d65e67dd1bec6eaaa44c4c3fa3</citedby><cites>FETCH-LOGICAL-c372t-b6945137a9db84a40827770742e2901e345ae8d65e67dd1bec6eaaa44c4c3fa3</cites><orcidid>0000-0002-8049-7867</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29485118$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bayrac, Abdullah Tahir</creatorcontrib><creatorcontrib>Akca, Oya Ercan</creatorcontrib><creatorcontrib>Eyidogan, Fusun Inci</creatorcontrib><creatorcontrib>Oktem, Huseyin Avni</creatorcontrib><title>Target-specific delivery of doxorubicin to human glioblastoma cell line via ssDNA aptamer</title><title>Journal of biosciences</title><addtitle>J Biosci</addtitle><addtitle>J Biosci</addtitle><description>Targeted drug delivery approaches have been implementing significant therapeutic gain for cancer treatment since last decades. Aptamers are one of the mostly used and highly selective targeting agents for cancer cells. Herein, we address a nano-sized targeted drug delivery approach adorned with A-172 glioblastoma cell-line-specific single stranded DNA (ssDNA) aptamer in which the chemotherapeutic agent Doxorubicin (DOX) had been conjugated. DNA aptamer, GMT-3, was previously selected for specific recognition of glioblastoma and represented many advantageous characteristics for drug targeting purposes. Flow cytometry analysis proved the binding efficiency of the specific aptamer to tumour cell lines. Cell-type-specific toxicity of GMT-3:DOX complex was showed by XTT assay and terminated cytotoxic effects were screened for both target cell and a control breast cancer cell line. The result of this contribution demonstrated the potential utility of GMT-3 aptamer-mediated therapeutic drug transportation in the treatment of gliomas specifically. It was concluded that aptamer-mediated drug delivery can be applied successfully for clinical use.</description><subject>Aptamers</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain cancer</subject><subject>Breast cancer</subject><subject>Cancer</subject><subject>Cell Biology</subject><subject>Cell lines</subject><subject>Cytometry</subject><subject>Cytotoxicity</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Doxorubicin</subject><subject>Drug delivery</subject><subject>Drug delivery systems</subject><subject>Drugs</subject><subject>Flow cytometry</subject><subject>Glioblastoma</subject><subject>Life Sciences</subject><subject>Microbiology</subject><subject>Plant Sciences</subject><subject>Toxicity</subject><subject>Transport</subject><subject>Tumor cell lines</subject><subject>Tumors</subject><subject>Zoology</subject><issn>0250-5991</issn><issn>0973-7138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kLtOwzAUhi0EgnJ5ABZkidlgx05tj1W5ShUsXZgsxzkpRklc7KRq356gFMTCdH7p_BfpQ-iS0RtGqbxNLKNcEcoU0ZJzsj1AEzooIhlXh4POckpyrdkJOk3pg1KmBafH6CTTQuWMqQl6W9q4go6kNThfeYdLqP0G4g6HCpdhG2JfeOdb3AX83je2xavah6K2qQuNxQ7qGte-BbzxFqd09zLDdt3ZBuI5OqpsneBif8_Q8uF-OX8ii9fH5_lsQRyXWUeKqRY549LqslDCCqoyKSWVIoNMUwZc5BZUOc1hKsuSFeCmYK0VwgnHK8vP0PVYu47hs4fUmY_Qx3ZYNExrnksmtBpcbHS5GFKKUJl19I2NO8Oo-WZpRpZmYGm-WZrtkLnaN_dFA-Vv4gfeYMhGQxpe7Qrin-l_W78AVe9_4w</recordid><startdate>20180301</startdate><enddate>20180301</enddate><creator>Bayrac, Abdullah Tahir</creator><creator>Akca, Oya Ercan</creator><creator>Eyidogan, Fusun Inci</creator><creator>Oktem, Huseyin Avni</creator><general>Springer India</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F1W</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H99</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L.F</scope><scope>L.G</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><orcidid>https://orcid.org/0000-0002-8049-7867</orcidid></search><sort><creationdate>20180301</creationdate><title>Target-specific delivery of doxorubicin to human glioblastoma cell line via ssDNA aptamer</title><author>Bayrac, Abdullah Tahir ; Akca, Oya Ercan ; Eyidogan, Fusun Inci ; Oktem, Huseyin Avni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-b6945137a9db84a40827770742e2901e345ae8d65e67dd1bec6eaaa44c4c3fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aptamers</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain cancer</topic><topic>Breast cancer</topic><topic>Cancer</topic><topic>Cell Biology</topic><topic>Cell lines</topic><topic>Cytometry</topic><topic>Cytotoxicity</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Doxorubicin</topic><topic>Drug delivery</topic><topic>Drug delivery systems</topic><topic>Drugs</topic><topic>Flow cytometry</topic><topic>Glioblastoma</topic><topic>Life Sciences</topic><topic>Microbiology</topic><topic>Plant Sciences</topic><topic>Toxicity</topic><topic>Transport</topic><topic>Tumor cell lines</topic><topic>Tumors</topic><topic>Zoology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bayrac, Abdullah Tahir</creatorcontrib><creatorcontrib>Akca, Oya Ercan</creatorcontrib><creatorcontrib>Eyidogan, Fusun Inci</creatorcontrib><creatorcontrib>Oktem, Huseyin Avni</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ASFA: Marine Biotechnology Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of biosciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bayrac, Abdullah Tahir</au><au>Akca, Oya Ercan</au><au>Eyidogan, Fusun Inci</au><au>Oktem, Huseyin Avni</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Target-specific delivery of doxorubicin to human glioblastoma cell line via ssDNA aptamer</atitle><jtitle>Journal of biosciences</jtitle><stitle>J Biosci</stitle><addtitle>J Biosci</addtitle><date>2018-03-01</date><risdate>2018</risdate><volume>43</volume><issue>1</issue><spage>97</spage><epage>104</epage><pages>97-104</pages><issn>0250-5991</issn><eissn>0973-7138</eissn><abstract>Targeted drug delivery approaches have been implementing significant therapeutic gain for cancer treatment since last decades. Aptamers are one of the mostly used and highly selective targeting agents for cancer cells. Herein, we address a nano-sized targeted drug delivery approach adorned with A-172 glioblastoma cell-line-specific single stranded DNA (ssDNA) aptamer in which the chemotherapeutic agent Doxorubicin (DOX) had been conjugated. DNA aptamer, GMT-3, was previously selected for specific recognition of glioblastoma and represented many advantageous characteristics for drug targeting purposes. Flow cytometry analysis proved the binding efficiency of the specific aptamer to tumour cell lines. Cell-type-specific toxicity of GMT-3:DOX complex was showed by XTT assay and terminated cytotoxic effects were screened for both target cell and a control breast cancer cell line. The result of this contribution demonstrated the potential utility of GMT-3 aptamer-mediated therapeutic drug transportation in the treatment of gliomas specifically. It was concluded that aptamer-mediated drug delivery can be applied successfully for clinical use.</abstract><cop>New Delhi</cop><pub>Springer India</pub><pmid>29485118</pmid><doi>10.1007/s12038-018-9733-x</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-8049-7867</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0250-5991
ispartof Journal of biosciences, 2018-03, Vol.43 (1), p.97-104
issn 0250-5991
0973-7138
language eng
recordid cdi_proquest_journals_1993571498
source Springer Link
subjects Aptamers
Biomedical and Life Sciences
Biomedicine
Brain cancer
Breast cancer
Cancer
Cell Biology
Cell lines
Cytometry
Cytotoxicity
Deoxyribonucleic acid
DNA
Doxorubicin
Drug delivery
Drug delivery systems
Drugs
Flow cytometry
Glioblastoma
Life Sciences
Microbiology
Plant Sciences
Toxicity
Transport
Tumor cell lines
Tumors
Zoology
title Target-specific delivery of doxorubicin to human glioblastoma cell line via ssDNA aptamer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T20%3A51%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Target-specific%20delivery%20of%20doxorubicin%20to%20human%20glioblastoma%20cell%20line%20via%20ssDNA%20aptamer&rft.jtitle=Journal%20of%20biosciences&rft.au=Bayrac,%20Abdullah%20Tahir&rft.date=2018-03-01&rft.volume=43&rft.issue=1&rft.spage=97&rft.epage=104&rft.pages=97-104&rft.issn=0250-5991&rft.eissn=0973-7138&rft_id=info:doi/10.1007/s12038-018-9733-x&rft_dat=%3Cproquest_cross%3E1993571498%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-b6945137a9db84a40827770742e2901e345ae8d65e67dd1bec6eaaa44c4c3fa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1993571498&rft_id=info:pmid/29485118&rfr_iscdi=true